Eli Lilly will spend at least $27 billion dollars to build four manufacturing plants in the U.S. in order to move production back to America.
New diabetes medications are pressuring Medicare Part D financially as they drive up prescription drug costs amid rising ...
After quite a crushing bull stampede in 2024, the stock price of weight loss drug star Novo Nordisk (NYSE: NVO) has come down ...
GLP-1 Receptor Agonist Market. The global GLP-1 receptor agonist market is on the verge of unprecedented growth, fueled by ...
Lars Fruergaard Jørgensen might not be a household name, but his company’s drug Ozempic is. And its success has thrust him — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results